Cellebrite DI Ltd.
NASDAQ:CLBTSoftware - Infrastructure
-$0.05 today
- Market cap
- $2.68B
- Beta
- 1.17
- P/E (TTM)
- 42.6
- EPS (TTM)
- $0.29
Volume 3.48M
Average 2.08M
CLBT Total Non-current Assets
All assets not expected to be converted to cash within one year.
Cellebrite DI Ltd.NASDAQ: CLBT
Total Non-current Assets · Q3 FY2026 · quarter ended Sep 2026
Total non-current assets rises 147.2% from a year ago
Total non-current assets stood at $410.07M at the end of Q3 FY2026, up 147.2% from a year earlier and down 0.2% from the prior quarter. Over 3 fiscal years it compounded at +50.1% a year.
Context
- Total non-current assets amounted to 38.4% of total assets at the end of Q3 FY2026, up 18.5 pp from a year earlier.
- Total non-current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps rising in the next quarterly balance sheet after a +147.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 363M USD
- Year-over-year change
- +195.2%
- 4-year CAGR
- +52.8%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 363M | +195.2% |
| FY2024 | 2024-12-31 | 122.97M | -0.7% |
| FY2023 | 2023-12-31 | 123.87M | +15.4% |
| FY2022 | 2022-12-31 | 107.36M | +61.3% |
| FY2021 | 2021-12-31 | 66.57M | — |
Total Non-current Assets vs competitors
How CLBT compares with its peers on the latest reported figures
- CLBT's Sep 2026 total non-current assets of $410.07M is the 2nd highest of the 4 companies compared; the peer median is $85.49M.
- Its year-over-year change of +147.2% is the highest of 4, against a peer median of +70.9%.
- Total non-current assets amounts to 38.4% of total assets for CLBT, versus a peer median of 51.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $4.55B | +86.5% | +46.4% | 51.5% | |
| Sep 2026 | $410.07M | +147.2% | +50.1% | 38.4% | |
| Mar 2026 | $85.49M | -6.5% | +3.7% | 68.0% | |
| Mar 2026 | $34.66M | +70.9% | +25.4% | 48.9% | |
| Peer median (excluding CLBT) | $85.49M | +70.9% | +25.4% | 51.5% | |
Competitors are the stored peer set for CLBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 145.97M | 87.65M | 189.52M | 191.66M | 124.46M |
| Short-term Investments | 35.59M | 95.98M | 113.41M | 255.56M | 312.59M |
| Net Receivables | 67.51M | 78.76M | 77.27M | 82.36M | 104.97M |
| Inventory | 6.51M | 10.18M | 9.94M | 8.94M | 7.6M |
| Other Current Assets | 7.88M | 14.77M | 23.06M | 18.18M | 6.6M |
| Total Current Assets | 273.21M | 295.93M | 422.08M | 567.59M | 575.85M |
| Property, Plant & Equipment (Net) | 16.76M | 32.91M | 30.16M | 27.6M | 38.52M |
| Goodwill | 26.83M | 26.83M | 26.83M | 28.71M | 119.56M |
| Intangible Assets | 11.23M | 11.25M | 10.59M | 11.31M | 81.47M |
| Long-term Investments | 0 | 22.13M | 28.86M | 36.6M | 97.96M |
| Tax Assets | 9.8M | 12.51M | 14.54M | 11.07M | 10.88M |
| Other Non-current Assets | 1.96M | 1.73M | 12.89M | 7.68M | 14.62M |
| Total Non-current Assets | 66.57M | 107.36M | 123.87M | 122.97M | 363M |
| Total Assets | 339.78M | 403.29M | 532.89M | 690.57M | 938.85M |
| Account Payables | 9.55M | 4.61M | 8.28M | 11.08M | 16.83M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 8.24M | 2.85M | 833K | 756K | 0 |
| Deferred Revenue | 123.68M | 153.34M | 196.59M | 217.64M | 278.24M |
| Other Current Liabilities | 0 | 0 | 9.04M | 0 | 0 |
| Total Current Liabilities | 186.57M | 207.78M | 253.82M | 295.5M | 369.66M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 36.43M | 42.17M | 47.1M | 45.25M | 49.53M |
| Other Non-current Liabilities | 190.13M | 69.13M | 188.59M | 6.95M | 16.68M |
| Total Non-current Liabilities | 226.56M | 121.65M | 244.85M | 59.05M | 84.88M |
| Total Liabilities | 413.13M | 329.43M | 498.67M | 354.55M | 454.53M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 78.44M | 199.24M | 118.14M | (164.86M) | (86.54M) |
| Accumulated OCI | 1.37M | 331K | 1.05M | 2.09M | 2.22M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (73.35M) | 73.87M | 34.21M | 336.02M | 484.32M |
| Total Debt | 0 | 15.36M | 14.13M | 10.97M | 22.67M |
| Net Debt | (145.97M) | (72.29M) | (175.39M) | (180.69M) | (101.79M) |
Cellebrite DI Ltd.
NASDAQ:CLBT
Intrinsic Alpha fair value
Locked
Current Price
$10.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.